Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

NCT04496882 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b
Hepatitis B Reactivation

Interventions

DRUG: Vemlidy

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]